Brain metastases in HER2-positive breast cancer

被引：8
|
作者：
Lin, Nancy U. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Div Womens Canc, Boston, MA 02215 USA
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 03期
关键词：
NERVOUS-SYSTEM METASTASES; TRASTUZUMAB; LAPATINIB; WOMEN;
D O I：
10.1016/S1470-2045(13)70046-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 186
页数：3
相关论文
共 50 条
  • [21] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, R.
    Berghoff, A. S.
    Rudas, M.
    Bergen, E.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Preusser, M.
    Steger, G. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S184 - S184
  • [22] Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases
    Ma, Xiaoping
    Li, Yan
    Li, Li
    Gao, Chunyan
    Liu, Dan
    Li, Hongyu
    Zhao, Zhenhui
    Zhao, Bing
    ANNALS OF MEDICINE, 2022, 54 (01) : 3085 - 3095
  • [23] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Gnant, Michael
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinksi, Christoph C.
    Steger, Guenther G.
    Preusser, Matthias
    CANCER RESEARCH, 2015, 75
  • [24] Activity of T-DM1 in Her2-positive breast cancer brain metastases
    Rupert Bartsch
    Anna S. Berghoff
    Ursula Vogl
    Margaretha Rudas
    Elisabeth Bergen
    Peter Dubsky
    Karin Dieckmann
    Katja Pinker
    Zsuzsanna Bago-Horvath
    Arik Galid
    Leopold Oehler
    Christoph C. Zielinski
    Michael Gnant
    Guenther G. Steger
    Matthias Preusser
    Clinical & Experimental Metastasis, 2015, 32 : 729 - 737
  • [25] T-DM1 in HER2-positive breast cancer brain metastases (BM).
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Rudas, Margareta
    Bergen, Elisabeth
    Gnant, Michael
    Dieckmann, Karin
    Pinker, Katja
    Zielinski, Christoph
    Steger, Guenther G.
    Preusser, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] HOSPITAL HEALTH CARE COSTS FOR THE MANAGEMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
    Baffert, S.
    Cottu, P.
    Kirova, Y.
    Bachelot, T.
    Mercier, F.
    Le Rhun, E.
    Levy, C.
    Gutierrez, M.
    Madranges, N.
    Moldovan, C.
    Coudert, B.
    Spaeth, D.
    Serin, D.
    Cotte, F. E.
    Benjamin, L.
    Simondi, C.
    Maillard, C.
    Laulhere-Vigneau, S.
    Durand-Zaleski, I
    VALUE IN HEALTH, 2011, 14 (07) : A441 - A441
  • [27] Occult brain metastases in HER2-positive breast cancer patients: Frequency and response to radiotherapy
    Niwinska, Anna
    Tacikowska, Malgorzata
    Pienkowski, Tadeusz
    ACTA ONCOLOGICA, 2007, 46 (07) : 1027 - 1029
  • [28] Activity of T-DM1 in Her2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Dubsky, Peter
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinski, Christoph C.
    Gnant, Michael
    Steger, Guenther G.
    Preusser, Matthias
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (07) : 729 - 737
  • [29] T-DM1 is active in Her2-positive breast cancer brain metastases
    Bartsch, R.
    Berghoff, A.
    Rudas, M.
    Bergen, E.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Steger, G. G.
    Preusser, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 195 - 195
  • [30] Local and systemic treatment for HER2-positive breast cancer with brain metastases: a comprehensive review
    Chan, Wing-Lok
    Lam, Tai-Chung
    Lam, Ka-On
    Luk, Mai-Yee
    Kai-Cheong, Roger Ngan
    Kwong, Lai-Wan Dora
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
12345